Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...

From cloud chaos to clarity.” In this episode, AT&T’s Erian Laperi, Kristina Sutton, and Dan Wagner discuss transforming one ...

Vertical farms, woke AI, and 23andMe made our annual list of failed tech. From chatbots dishing out illegal advice to dodgy ...

While 23andMe’s privacy statement has changed since ... publicized 23andMe data to try to find a match. And who knows what AI systems will be able to learn based on our DNA, and all the ways ...

Related: Stop giving your DNA data away for free to 23andMe, says Genomes.io CEO ... like training an AI model, without anyone who owns any bit of data having to share it with any of the ...

Chinese AI startup DeepSeek is facing a cyberattack ... its customer payment portal offline while it mitigates the issue. 23andMe agreed to pay $30 million to settle a class action lawsuit from ...

The struggling genetic-testing company 23andMe has been quietly exploring a possible sale of its telehealth offering, Business Insider has learned. 23andMe has been testing the waters for a buyer ...

23andMe has been exploring a possible sale of its telehealth business, Business Insider has learned. The struggling health company bought the virtual-care startup Lemonaid in 2021 for $400 million ...